Search results
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 16 hours agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Obituary For Eminem’s Alter Ego Slim Shady Published In Detroit Newspaper
HuffPost· 1 day agoThe promotional stunt certainly teases a return to horrorcore for Eminem, whose 2009 effort “Relapse...
Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma
Morningstar· 14 hours agoBristol Myers Squibb has won U.S. Food and Drug Administration expanded approval of its CAR-T cell therapy Breyanzi for adults with relapsed or refractory ...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 18 hours agoThe drug is a multi-selective non-covalent inhibitor designed to treat patients with cancers driven by a wide range of common RAS mutations. ...clinical...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 12 hours agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 17 minutes agoHONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib,
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 20 hours agoA third cohort includes treating refractory relapsed AML patients who are venetoclax resistant or intolerant with the two-drug combination of prexigebersen ...
Drug Court alumni and enrollees holding 'Walk for Recovery' on Monday in Centralia, public invited...
The Chronicle, Centralia, Wash. via Yahoo News· 6 days agoMay 10—On Monday, May 13, beginning at 5:30 p.m., Lewis County Drug Court alumni and current enrollees will set out for the 2024 Walk for Recovery from Gather Church's cafe ...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 8 hours agoThe FDA extended the review time for the above BLA... (lisocabtagene maraleucel; liso-cel). The...
US overdose deaths decline for first time in 5 years as Michigan sees dip, too
Detroit Free Press· 1 day agoThe number of people who died as a result of drug overdoses declined by 3% across the nation last...
